Entity
  • Pearce IP

    Created in 2017
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,638
  • Activities

  • Technologies

  • Entity types

  • Location

    Level 3/32 Martin Pl, Sydney NSW 2000, Australia

    Sydney

    Australia

  • Employees

    Scale: 11-50

    Estimated: 19

  • Engaged corporates

    11
    0 11
  • Added in Motherbase

    1 month, 3 weeks ago
Description
  • Value proposition

    A boutique life sciences focussed intellectual property firm in Australia and New Zealand.

    Pearce IP is an award winning, market leading, boutique intellectual property firm offering life sciences focussed lawyers and attorneys with science backgrounds.

    Pearce IP is the 2021 ‘Intellectual Property Team of the Year’ (Lawyers Weekly Australian Law Awards) and was shortlisted for the same award in 2022. Pearce IP is ranked in IAM Patent 1000 and Managing IP (MIP) IP Stars, in Australasian Lawyer 5 Star Awards as a ‘5 Star’ firm, and the Legal 500 APAC Guide for Intellectual Property. Pearce IP leaders are well recognised as leading IP practitioners.

    We coordinate and execute local and multi-jurisdictional IP litigation strategies, provide IP/legal support for regional and global business development activities and licensing deals, and prosecute patent and trade mark applications around the world.

    Intellectual property, Patents, Pharmaceuticals, Biosimilars, Biopharmaceuticals, Global IP Strategies, Patent Litigation, Commercialisation, biotechnology, trade marks, patent prosecution, regulatory, agritech, foodtech, cell therapy, gene therapy, CRISPR, and medtech

  • Pearce IP | Biopharma & Life Sciences Patent Lawyers in AU & NZ

    Intellectual property specialist lawyers, patent & trade mark attorneys, to the pharmaceutical, biopharmaceutical & life sciences industries.

  • https://www.pearceip.law/
Corporate interactions BETA
Corporate TypeTweets Articles
Daiichi Sankyo
Daiichi Sankyo
Pharmaceutical
Daiichi Sankyo
Pharmaceutical
Other

3 Mar 2025


Regeneron
Regeneron
Pharmaceutical, Biotechnology, Biotechnology Research
Regeneron
Pharmaceutical, Biotechnology, Biotechnology Research
Other

3 Mar 2025


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

3 Mar 2025


Roche
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Other

3 Mar 2025


Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Other

3 Mar 2025


MSD
MSD
Pharmaceutical, Pharmaceutical Manufacturing
MSD
Pharmaceutical, Pharmaceutical Manufacturing
Other

3 Mar 2025


Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Other

20 Feb 2025


Amgen
Amgen
Biotechnology, Biotechnology Research
Amgen
Biotechnology, Biotechnology Research
Other

13 Feb 2025


Teva Pharmaceuticals
Teva Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Teva Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Other

27 Feb 2025


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Other

3 Mar 2025


Similar entities
Loading...
Loading...
Social network dynamics